Can We Change the Course of Beta-Cell Destruction in Type 1 Diabetes
Anti-endothelial cell antibodies in chronic leg ulcers: prevalence and significance
Primary Anti-Phospholipid Antibody Syndrome (APS). Current Concepts

Endothelium as a target for anti-phospholipid antibodies and for therapeutical intervention
"Hughes syndrome" crosses boundaries
Primary Anti-Phospholipid Antibody Syndrome (APS). Current Concepts

Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases
Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics
Immune Thrombocytopenic Purpura
Bullous Pemphigoid Therapy — Think Globally, Act Locally
Maternal Antibodies, Childhood Infections, and Autoimmune Diseases

Is peripartum cardiomyopathy an organ-specific autoimmune disease?
Iodine: an environmental trigger of thyroiditis

Autoimmunization to Epidermal Growth Factor, a component of the immunological homunculus
The "Autoimmune Diseases" 40th anniversary
Autoimmunity at a turning point: from investigation to intervention
Intravenous immunoglobulin (IVIG) therapy for immunologic abortion
Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease

Can We Change the Course of Beta-Cell Destruction in Type 1 Diabetes
Caught by a Masquerade. Sclerosing Orbital Inflammation
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis
Mycophenolate mofetil decreases antibody production after cardiac transplantation

Immunomodulation for treatment and prevention of atherosclerosis
CD40-CD40L Interactions in Atherosclerosis
Anti-endothelial cell antibodies in chronic leg ulcers: prevalence and significance
